Abstract
The in vitro and in vivo antibacterial activity of TE- 031 (A-56268) was comparedwith those of erythromycin (EM), josamycin (JM) and other antibiotics. The following results were obtained. 1. TE-031 had the same antibacterial spectrum as EM, being active against aerobicGram-positive and -negative bacteria (B. catarrhalis, N. gonorrhoeae, H. influenzae), anaerobic bacteria, L-form bacteria and M. pneumoniae. 2. TE-031 was equally or slightly more active than EM and more active than JM against 388 strains of clinical isolates. 3. TE-031 showed bactericidal activity against H. influenzae, as did EM. 4. TE- 031 was more effective than EM and JM against systemic, subcutaneous and respiratory tract infections in mice. © 1988, Japanese Society of Chemotherapy. All rights reserved.
Cite
CITATION STYLE
Nagate, T., Sugita, K., Numata, K., Ono, T., Miyachi, J., Morikawa, E., & Omura, S. (1988). Antibacterial activity of TE-031 (A-56268), a new macrolide antibiotic. CHEMOTHERAPY, 36, 129–155. https://doi.org/10.11250/chemotherapy1953.36.Supplement3_129
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.